Last reviewed · How we verify
NCT05094505
Isolated and Combined Effect of a Low Carbohydrate Diet and Exercise in Hypoxia in Patients With Type 2 Diabetes
NA trial testing Exercise in normoxia in Carbohydrate in 42 participants. Completed in 18 July 2023.
18 July 2023
Quick facts
| Lead sponsor | Universidade do Porto |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 42 |
| Start date | 1 October 2021 |
| Primary completion | 18 July 2023 |
| Estimated completion | 18 July 2023 |
| Sites | 2 locations across Portugal |
Drugs / interventions tested
- Exercise in normoxia
- Control diet
- Exercise in hypoxia
- Low carbohydrate diet
Conditions studied
- Carbohydrate — all drugs for Carbohydrate →
- Hypoxia — all drugs for Hypoxia →
- Exercise — all drugs for Exercise →
- Diabetes Mellitus, Type 2 — all drugs for Diabetes Mellitus, Type 2 →
Sponsor
Universidade do Porto — full company profile →
Who can join
Under 75, any sex, with Carbohydrate or Hypoxia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to determine the effects of isolated chronic exercise in hypoxia and combined exercise in hypoxia with a low carbohydrate diet on hypoxia-induced transcription factor (HIF1-α); glycaemic control and cardiovascular risk factors in patients with type 2 diabetes.
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
Eight Weeks of Intermittent Exercise in Hypoxia, with or without a Low-Carbohydrate Diet, Improves Bone Mass and Functional and Physiological Capacity in Older Adults with Type 2 Diabetes.
Kindlovits R, Sousa AC, Viana JL, Milheiro J, et al · · 2024 · cited 9× · PMID 38892557 · DOI 10.3390/nu16111624 -
Evaluating the Therapeutic Potential of Exercise in Hypoxia and Low-Carbohydrate, High-Fat Diet in Managing Hypertension in Elderly Type 2 Diabetes Patients: A Novel Intervention Approach.
Kindlovits R, Sousa AC, Viana JL, Milheiro J, et al · · 2025 · cited 4× · PMID 39940380 · DOI 10.3390/nu17030522 -
Combined low-carbohydrate diet and long-term exercise in hypoxia in type 2 diabetes: A randomized controlled trial protocol to assess glycemic control, cardiovascular risk factors and body composition.
Kindlovits R, Sousa AC, Viana JL, Milheiro J, et al · · 2024 · cited 4× · PMID 37499218 · DOI 10.1177/02601060231190663 -
Evaluating the Therapeutic Potential of Exercise in Hypoxia and Low-Carbohydrate High-Fat Diet in Managing Hypertension in Elderly Type 2 Diabetes Patients: A Novel Intervention Approach
Kindlovits R, Sousa AC, Viana JL, Milheiro J, et al · · 2025 · DOI 10.20944/preprints202501.0270.v1
Verify or expand the search:
- PubMed search for NCT05094505
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Exercise in normoxia
Trials testing the same drug.
- NCT04450745 — Physical Exercise in Normobaric Hypoxia and Normoxia in Type 1 Diabetic Patients · NA · completed
Other Universidade do Porto trials
Trials by the same sponsor.
- NCT07457697 — MyGENESIS: A Digital Psychoeducational Program for Donor-Conceived Young Adults · NA · not yet recruiting
- NCT07503990 — Effects of Food Intake Sequence on Substrate Utilisation and Endurance Performance · NA · recruiting
- NCT07436091 — Porcine Derma for Soft Tissue Augmentation Around Implants · NA · not yet recruiting
- NCT07498556 — Immediate Restoration of a New Implant With High Primary Stability · NA · not yet recruiting
- NCT07448870 — Evaluating the Mentalization-based Treatment Lighthouse Parenting Programme: Protocol of a Feasibility and Acceptability · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05094505 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidade do Porto
- Last refreshed: 19 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05094505.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing